NanoGroup S.A.

Warsaw Stock Exchange NNG.WA

NanoGroup S.A. Price to Sales Ratio (P/S) on January 14, 2025: 43,209.58

NanoGroup S.A. Price to Sales Ratio (P/S) is 43,209.58 on January 14, 2025, a 272.23% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • NanoGroup S.A. 52-week high Price to Sales Ratio (P/S) is 52,012.66 on September 18, 2024, which is 20.37% above the current Price to Sales Ratio (P/S).
  • NanoGroup S.A. 52-week low Price to Sales Ratio (P/S) is 10,491.74 on February 13, 2024, which is -75.72% below the current Price to Sales Ratio (P/S).
  • NanoGroup S.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 26,906.02.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Warsaw Stock Exchange: NNG.WA

NanoGroup S.A.

CEO Mr. Przemyslaw Daniel Mazurek
IPO Date March 14, 2018
Location Poland
Headquarters Rakowiecka 36
Employees 46
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.

StockViz Staff

January 15, 2025

Any question? Send us an email